Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study links polycystic ovary syndrome with early vascular changes of heart disease

10.11.2004


University of Pittsburgh Researchers note particular risk for women with both metabolic cardiovascular and polycystic ovary syndromes



Polycystic ovary syndrome (PCOS), a disorder characterized by metabolic and endocrine abnormalities, affects millions of women in the United States alone and endangers their hearts by causing early buildup of calcium in coronary arteries, researchers at the University of Pittsburgh’s Graduate School of Public Health report in the November issue of the Journal of Clinical Endocrinology and Metabolism.

"Our findings indicate a strong correlation between PCOS, metabolic cardiovascular syndrome and initial evidence of calcium deposits that signal blood vessel disease," said Evelyn Talbott, Dr. P.H., professor of epidemiology and communication science at the University of Pittsburgh Graduate School of Public Health and the study’s first author. "Given the large number of women with PCOS and the long incubation period for calcium accumulation in coronary arteries, early and aggressive intervention through lifestyle changes and medication may significantly reduce heart disease-related death and illness."


PCOS is a common disorder that affects up to 7 percent of the female population, or about 10 million women in the United States. Some estimates are that as many as 10 percent of reproductive-age women are affected by PCOS. Previously treated on a symptom-by-symptom basis by physicians unaware that a larger and more complicated ailment was present, PCOS today is increasingly being recognized as a lifelong hereditary reproductive endocrine condition with physical and emotional consequences. Common symptoms include infertility, irregular menstrual cycles, excess body hair, ovarian cysts, acne and obesity. The American Association of Clinical Endocrinologists issued a position paper just weeks ago to raise awareness of the disorder, saying that women with PCOS "are at greatest risk for diabetes and coronary artery disease."

Dr. Talbott’s study involved 61 women with PCOS who underwent noninvasive electron beam tomography scanning of their coronary and abdominal arteries. Results for the 61 women with PCOS were compared with those for control subjects matched for age, race and body weight, and overall values were compared with recorded baseline measurements taken in 1992 and 1993, an average of nine years earlier. The heaviest women were excluded in order to make sure arterial changes correlated most closely with PCOS rather than other risk factors known to be associated with obesity.

"After adjustment for age and body-mass index, PCOS was a significant predictor of coronary-artery calcium deposits," said Dr. Talbott. "Women with PCOS were more than twice as likely to exhibit these subclinical arterial changes – that is, before symptoms appeared."

Women with PCOS who also had metabolic cardiovascular syndrome (MCS), which is associated with insulin resistance, increased waist size and high blood pressure, were found to be at an even greater risk of calcification in coronary and abdominal arteries, the study found. PCOS-affected women were more than four times more likely to have MCS than those in the control group who did not have PCOS. "This is the first study to demonstrate a link between the specific components of MCS in younger women with PCOS and subsequent subclinical coronary atherosclerosis observed at the nine-year follow-up," she added.

Perhaps most interesting, however, was a finding that higher blood levels of testosterone were associated with increased risk of aortic calcifications in all women, whether they had an endocrine disorder or not. Earlier studies have noted such a correlation in women over the age of 55, but this study found a similar link in women in their 40s. "These results are provocative and show the need for further investigation of testosterone and PCOS as the two relate to heart and blood vessel disease in later life," said Dr. Talbott.

Michele D. Baum | EurekAlert!
Further information:
http://www.upmc.edu

More articles from Studies and Analyses:

nachricht Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT

nachricht Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Closing the carbon loop

08.12.2016 | Life Sciences

Applicability of dynamic facilitation theory to binary hard disk systems

08.12.2016 | Physics and Astronomy

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>